Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)

Παρόμοια τεκμήρια

• Pharmacokinetic analysis of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in individuals with renal impairment compared to healthy controls
  ανά: Scheerans, Christian, κ.ά.
  Έκδοση: (2011)
• Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
  ανά: Radovits, Tamás, κ.ά.
  Έκδοση: (2009)
• Structure of Cinaciguat (BAY 58–2667) Bound to Nostoc H-NOX Domain Reveals Insights into Heme-mimetic Activation of the Soluble Guanylyl Cyclase
  ανά: Martin, Faye, κ.ά.
  Έκδοση: (2010)
• The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems
  ανά: Vandendriessche, Benjamin, κ.ά.
  Έκδοση: (2013)
• The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
  ανά: Vandendriessche, Benjamin, κ.ά.
  Έκδοση: (2013)